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Available online 4 August 2016Cell-to-cell junctions are critical for the formation of endothelial barriers, and its disorganization is required for
sprouting angiogenesis. Members of the angiomotin (AMOT) family have emerged as key regulators in the con-
trol of endothelial cell (EC) junction stability and permeability. However, the underlying mechanism by which
the AMOT family is regulated in ECs remains unclear. Herewe report that HECW2, a novel EC ubiquitin E3 ligase,
plays a critical role in stabilizing endothelial cell-to-cell junctions by regulating AMOT-like 1 (AMOTL1) stability.
HECW2 physically interacts with AMOTL1 and enhances its stability via lysine 63-linked ubiquitination. HECW2
depletion in human ECs decreases AMOTL1 stability, loosening the cell-to-cell junctions and altering subcellular
localization of yes-associated protein (YAP) from cytoplasm into the nucleus. Knockdown of HECW2 also results
in increased angiogenic sprouting, and this effect is blocked by depletion of ANG-2, a potential target of YAP.
These results demonstrate that HECW2 is a novel regulator of angiogenesis and provide new insights into the
mechanisms coordinating junction stability and angiogenic activation in ECs.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Angiogenesis is a process that forms new blood vessels and is co-
ordinated by the dynamics of quiescent and activated endothelial
cells (ECs). The quiescent state of ECs is maintained until they re-
spond to pro-angiogenic factors, such as VEGF and ANG-2, which
promote the liberation of ECs by loosening cell-to-cell junctions [1,
2]. Once the junctions become disorganized, subsequent intracellu-
lar signaling induces cells to actively proliferate and migrate to
form new vessels. Conversely, when ECs come into close contact
with each other, actively proliferating ECs form stable intercellular
junctions [3,4]. Regulation of endothelial cell-to-cell junctions is crit-
ically important in angiogenesis, and incorrect junctional permeabil-
ity is the primary contributing factor for morbidity and mortality in
vascular diseases [5,6].in-like 1; AMOTL2, angiomotin-
etin-2; VE-cadherin, vascular
C, outgrowing endothelial cell;
elial cell.
try, College of Life Science and
c of Korea.
. This is an open access article underThe angiomotin (AMOT) family is characterized as a group of tight
junction proteins that are expressed in ECs and regulate vascular per-
meability [7–10]. For example, AMOT co-localizes with ZO-1 by cell-
to-cell contacts in ECs. In addition, ectopic expression of AMOT results
in decreased permeability compared with that in control cells [7], and
loss of AMOT-like 1 (AMOTL1) in ECs results in increased vascular per-
meability in vitro. Further, AMOTL1-transfected morphant zebraﬁsh
showed decreased junction stability of stalk cells in the dorsal aorta in
vivo [8]. Moreover, AMOT-like 2 (AMOTL2) associated with VE-
cadherin for transmission of mechanical force during aortic vessel
lumen expansion [11]. A recent study showed that the protein stability
of AMOTL1 was required for the formation of the tight junctions [12].
Nevertheless, the mechanism by which AMOTL1 stability is regulated
in ECs remains largely unknown.
HECW2, also known as Nedd4-like E3 ubiquitin-protein ligase
(NEDL) 2, belongs to the NEDD4 family, which includes nine other
members: NEDD4, NEDD4-2, ITCH, SMAD-speciﬁc E3 ubiquitin protein
ligase (SMURF) 1, SMURF2, WW domain-containing E3 ubiquitin pro-
tein ligase (WWP) 1, WWP2, NEDL1, and NEDL2 [13–18]. This family
of proteins is characterized by distinct domains: a Ca2+/lipid-binding
domain (C2 domain) involved in membrane targeting, 2–4 WW do-
mains that interact with a PPXYmotif, and homologous with E6-associ-
ated protein C-terminus (HECT)-type ligase domain required forthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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processes, such as proliferation, migration, differentiation, invasion,
and neuronal cell apoptosis via regulation of target protein interaction
with the WW-PPXY domains [19–22].
We recently proposed a molecular mechanism involving the YAP in
vascular ECs. YAP is a transcriptional co-activator that plays a role in
maintaining cellular homeostasis [23]. YAP was found to be expressed
in the angiogenic front region where vessels were sprouting and regulat-
ed by the VE-cadherin-mediated PI3K/AKT pathway. Once YAP was acti-
vated by disruption of junctions, YAP translocated into the nucleus and
induced ANG-2 expression, thereby promoting angiogenic sprouting in
vitro [24].
Here we investigate the role of HECW2 in ECs. We demonstrate that
HECW2 enhances endothelial cell-to-cell junctions through the regula-
tion of AMOTL1 protein stability via lysine 63-linked polyubiquitination.
Furthermore, depletion of HECW2 stimulates YAP translocation into the
nucleus, thereby promoting EC sprouting via increasedANG-2 expression.
2. Materials and methods
2.1. Cell culture and antibodies
Humanumbilical vein ECs (HUVECs)were isolated fromhuman um-
bilical cord veins using collagenase, as previously described [25], and
cells (between passage 2 and 7) were cultured on 2% gelatin-coated
dishes using M199 medium (Invitrogen, Carlsbad, CA), containing 20%
FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 3 ng/ml basic ﬁbro-
blast growth factor (R&D systems, Minneapolis, MN, USA), and 5 U/ml
heparin. HUVECs were grown at 37 °C in a humidiﬁed 95%/5% (vol/
vol) mixture of air and CO2. The following antibodies were used:
HECW2 and AMOTL1 (Atlas Antibodies, Stockholm, Sweden); ANG-2
(R&D systems, Minneapolis, MN, USA); YAP, LAMIN A/C, GFP, GAPDH,
and β-ACTIN (Santa Cruz Biotechnology, Santa Cruz, CA, USA);
phospho-YAP (S127; Cell Signaling, Danvers, MA, USA); and
angiopoetin-2 (R&D systems, Minneapolis, MN, USA).
2.2. Plasmids
The HECW2 and AMOTL1 open-reading frame (ORF)-containing
plasmids Flag-HECW2 WT, FLAG-AMOTL1 and 2, and HA-HECW2 WT
were generated in the Vascular genomics laboratory, Yonsei University.
The AMOT130 ORF-containing plasmid HA-AMOT130 was purchased
from Addgene (Cambridge, MA, USA), and AMOT130 ORF was
subcloned into a FLAG vector. The HECW2 C1540Amutantwas generat-
ed by site-directed mutagenesis. HECW2 deletion mutants were gener-
ated by polymerase chain reaction (PCR). V5-Ubwas kindly provided by
Dae-Won Kim (Yonsei University). pHM6-HA-Ub and mutants were
kindly provided by Jaewhan Song (Yonsei University). pEGFP-C2 was
used as a transfection control (Clontech, San Diego, CA).
2.3. Transfection of siRNA
HUVECs were transfected with scrambled and HECW2 siRNAs using
the Lipofectamine reagent (Invitrogen, Carlsbad, CA, USA) for 3 h. Efﬁ-
ciency of siRNA was assessed by RT-PCR and Western blot 48 h after
transfection. siRNA targeting HECW2 was purchased from Dharmacon
Inc. (siGENOME HUMAN (MQ-007192-00-0005)) (Lafayette, CO, USA).
2.4. Immunoprecipitation
HUVECs were plated on 100-mm-diameter dishes. The cells were
lysed with lysis buffer [150 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40,
0.5% Triton X-100, 0.1% sodium deoxycholate, 50 mM Tris-HCl
(pH 7.5), 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl ﬂuoride,
and a protease inhibitor mixture]. After centrifugation for 10 min at
13,000 rpm, the supernatant was removed, and the cell lysate wasincubatedwith indicated antibodies for 12 h at 4 °C. The cells were incu-
bated with protein G-Sepharose beads (GE Healthcare, Buckingham-
shire, United Kingdom) for 2 h at 4 °C. The samples were then
centrifuged and washed three times with lysis buffer and added to 2×
sample buffer and then boiled.
2.5. Ubiquitination assay
HEK293T cells were transfected with plasmids expressing FLAG-
AMOTL1, HA-HECW2, and HA-tagged Ub. After 24 h of transfection,
the cells were lysed and harvested in phosphate-buffered saline (PBS)
containing 10 nM NEM to prevent deubiquitination. Cells were lysed
in 1% SDS by boiling for 10 min, followed by dilution to 0.1% SDS by
the addition of lysis buffer, protease inhibitors, and NEM. Lysed samples
were immunoprecipitated with a FLAG antibody (Sigma-Aldrich, St.
Louis, MO, USA), followed by Western blotting.
2.6. Fibrin gel beads sprouting assay
HUVECs were mixed with dextran-coated Cytodex 3 microcarriers
(Amersham Pharmacia Biotech, Piscataway, NJ, USA) at a concentration
of 400 HUVECs per bead in 1 ml of EGM-2 medium (Clonetics,
Walkersville, MD, USA). Beads with cells were shaken gently every
20 min for 4 h at 37 °C and 5% CO2. After incubation, mixtures of
beads and cells were transferred to a 25-cm2 tissue culture ﬂask (BD
Biosciences, Bedford, MA, USA) and incubated in 12–16 h in 5 ml of
EGM-2 at 37 °C and 5% CO2. The following day, mixtures of beads and
cells were washed three times with 1 ml EGM-2 and were resuspended
at a concentration of 250 cell-coated beads/ml in 2 mg/ml ﬁbrinogen
(Sigma)with 0.15U/ml of aprotinin (Sigma) at a pHof 7.4. Five hundred
microliters of ﬁbrinogen/bead solution was added to 1 unit of thrombin
(Sigma) in 1 well of a 24-well tissue culture plate. The ﬁbrinogen/bead
solution was allowed to clot for 5 min at room temperature and for
20 min at 37 °C and 5% CO2. One milliliter of EGM-2 (which contains
10% FBS) was added to each well and was equilibrated with the ﬁbrin
clot for 30 min at 37 °C and 5% CO2. The medium was removed from
the well and replaced with 1 ml of fresh mediumwith or without addi-
tional growth factors. Twenty thousand skin ﬁbroblasts were plated on
the clot and the medium was changed every other day. Bead assays
were monitored for 10 days.
2.7. Immunoﬂuorescence staining
Scramble orHECW2siRNA-transfectedHUVECs cultured on coverslips
in a 12-well plate were ﬁxed with 4% paraformaldehyde ((PFA)-PBS) at
room temperature for 20 min and were permeabilized with 0.1% Triton
X-100 in PBS with Tween-20 for 15 min. After blocking by addition of
1% bovine serum albumin in PBS with Tween 20 for 1 h, cells were incu-
bated with primary antibodies in blocking buffer at 4 °C overnight. After
washing with PBS, cells were incubated with Alexa Fluor 488 goat anti-
mouse for 30 min at room temperature. Nuclei were stained with 4, 6
diamidino-2-phenylindole (DAPI; Molecular Probes, Carlsbad, California,
USA). Cells weremounted, and images were acquired by a laser scanning
confocal microscope (LSM 700 META, Carl Zeiss). For quantiﬁcation, at
least 500 cells were counted in each sample.
2.8. Lentivirus production
Human TRC HECW2 shRNA constructs were purchased from
Dharmacon (RHS4533-EG57520). To produce the lentivirus, pLenti-
shHECW2 and 2nd generation packaging DNA were transfected into
HEK293T cells. After 48 h, the supernatant was harvested and ﬁltered
using a 0.45 μm ﬁlter to remove cellular debris. Lentivirus was titrated
to 107 TU per ml.
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HUVECs were grown until conﬂuent on 0.1% gelatin-coated
Transwell™ ﬁlters (Corning Costar). Cells were serum-starved inFig. 1.HECW2 regulates EC junction stability and sprouting angiogenesis. (A, B) Various human
cell lysates were immunoblotted with anti-HECW2 and anti-beta-ACTIN antibodies. cDNA w
HECW2 and beta-ACTIN (C) Immunoﬂuorescence staining of HECW2 in human brain section
analysis of EC junctions in HECW2 siRNA-treated HUVECs was performed using antibodies ag
HUVECs increased with HECW2 depletion compared with that of cells transfected with con
permeability of the monolayer to 70 kDa FITC-dextran was evaluated at 0, 15, 60, and 240 m
control shRNA (shCON) or HECW2-targeting shRNA, the bead-sprouting assay was performed
or cumulative sprout length derived per bead was counted after 6 days of incubation. Data
versus shRNA-infected CON cells. (two-tailed Student's t-test).endothelial serum-free medium for 2 h. FITC-dextran (1 mg/ml;
Sigma) was added to the upper compartment. Absorbance from the
lower chamber solution was measured at 492 nm excitation and
520 nm emission in a FLUOstar Omega.endothelial and non-endothelial cell lines were analyzed byWestern blot or RT-PCR. The
as synthesized from mRNA extracted from the cells and was analyzed using primers for
s was performed using anti-CD31 and anti-HECW2 antibodies. (D) Immunoﬂuorescence
ainst ZO-1. The arrows indicate disrupted junctions. (E) The paracellular permeability of
trol siRNA. siRNA-transfected HUVECs were seeded at conﬂuence on a well insert. The
in by measuring ﬂuorescence of the lower well. (F) After HUVECs were infected with
and was replenished with 2% EGM medium every other day. (G) The number of sprouts
are shown as mean ± SEM. of values from a representative experiment. ***p b 0.0001
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Data are presented as mean ± SEM. Statistical analyses involved
Student's t-test and one-way analysis of variance (ANOVA). pvalues of
0.05 were considered signiﬁcant.
3. Results
3.1. HECW2 is highly expressed in endothelial cells
Using Affymetrix oligonucleotide arrays, we have identiﬁed various
genes that are regulated during EC differentiation from endothelial pro-
genitor cells (GEO Accession No. GSE12891) [26]. In this study, we fo-
cused on ubiquitin E3 ligases because regulation of junction protein
stability is important in maintenance of vascular integrity. We exam-
ined HECT ubiquitin ligase family member expression in ECs. Among
them, compared with other gene members, HECW2 showed relatively
speciﬁc expression in differentiated ECs (Supplementary Fig. 1A and
B). RT-PCR and Western blot analyses also conﬁrmed that compared
with early stage EPCs, HECW2 is highly expressed in OECs and HUVECs
(Fig. 1A and B). Furthermore, immunostaining of human brain sections
revealed that HECW2 co-localized with CD31, a well-known EC marker
(Fig. 1C), suggesting that HECW2 may play a role in EC function.
3.2. HECW2 depletion leads to disruption of junctions and promotes angio-
genic sprouting
To understand the role of HECW2 in ECs, we silenced endogenous
HECW2 gene using siRNA. First, we examined whether siRNA of
HECW2 effectively targeted the HECW2 gene in HUVECs. We used
four different siRNAs for HECW2. All siRNAs showed high efﬁciency
(Supplementary Fig. 3A). To reduce cytotoxicity and off-target effects,
we pooled the siRNAs. Then, using siRNA-targeted knockdown of
HECW2,we evaluated the effects of this protein on EC properties impor-
tant for cellular functions, such as cell junction, permeability, and
sprouting. Knockdown of HECW2 showed breakage of junctions and in-
creased EC permeability. Scrambled siRNA-transfected cells showed
well-organized junctions, whereas the junctions in HECW2-silenced
cells were disrupted (Fig. 1D). Permeability analysis using transwell re-
vealed that HECW2 siRNA-transfected cells showed increased perme-
ability (Fig. 1E). These data suggest that HECW2 may play a role in EC
junction stability. To further understand the role of HECW2, we exam-
ined EC sprouting using a three-dimensional ﬁbrin gel bead assay.
Knockdown of HECW2 using lentiviruses increased EC sprouting (Fig.
1F and G). Taken together, these data indicate that HECW2 may be in-
volved in the regulation of junction stability and angiogenic activation.
3.3. HECW2 interacts with AMOTL1
HECT-type E3 ligases mainly regulate target proteins through inter-
action with their WW-PPxY domain. Many groups have identiﬁedWW
domain-interacting proteins through cDNA libraries and yeast two-hy-
brid analyses [27–30]. Among various candidates, we selected the
AMOT family because of functional studies that establish their role in
angiogenesis [31]. The AMOT family has three members: AMOT,
AMOTL1, and AMOTL2. The AMOT family is a group of angiogenic regu-
lators which are involved in cell polarity, junction regulation, and
sprouting angiogenesis [8]. All members are capable of interacting
with the HECW2 protein (Supplementary Fig. 2A and B). However,
AMOT and AMOTL1, but not AMOTL2, were stabilized by HECW2 (Sup-
plementary Fig. 2C). Because AMOT expression was barely detected in
ECs, we focused on AMOTL1 (Supplementary Fig. 2D). To test whether
HECW2 interacts with AMOTL1 in ECs, HUVECs cell lysates were ana-
lyzed using IP-Western blotting. Western blotting analysis revealed
that HECW2 speciﬁcally interacts with AMOTL1 (Fig. 2A–D). Because
HECW2 has twoWW domains and AMOTL1 contains twoWW bindingproline-rich (P-Y) motifs, the relative abilities of the WW domains of
HECW2 to bind AMOTL1 were determined. We generated seven
HECW2 mutants that were distinguishable by mutations in their WW
domains to identify the interaction motif of AMOTL1. HECW2 WT and
four mutants (807-1572, 807-1012, 324-1012, and 1-1213) contained
the WW domain while the rest of the mutants do not (Fig. 2E). HECW
WT and WW-containing mutants interacted with AMOTL1 (Fig. 2F).
These data revealed that the WW domain of HECW2 contributed to
the interaction with AMOTL1.
3.4. HECW2 stabilizes AMOTL1 through lysine 63-linked polyubiquitination
A previous study demonstrated that NEDD4.2, one of HECT E3 li-
gases, targeted AMOTL1 for ubiquitin-dependent degradation [12]. Un-
like NEDD4.2, HECW2 targeted AMOTL1 and promoted its stability.
HECW2 and AMOTL1 were transfected into HEK293T cells in a concen-
tration-dependent manner. Overexpressed HECW2 induced stabiliza-
tion of exogenous AMOTL1 (Fig. 3A). As described above, HECW2
contains a C-terminal catalytic HECT domain with a conserved catalytic
cysteine located in its HECT domain.When HECW2 C1540wasmutated
to an A residue, the E3 ligase activity was completely abolished [32]. To
examine whether AMOTL1 was stabilized by ubiquitination, we gener-
ated a dominant negative mutant in which alanine was substituted for
the 1540th cysteine residue. This C1540Amutant lost its ability to stabi-
lize AMOTL1 (Fig. 3B). Because HECW2 interacted with AMOTL1, we in-
vestigated whether the role of HECW2 in AMOTL1 protein stability was
to act as an ubiquitin ligase. Thus, we performed an in vivo
ubiquitination assay to assess whether HECW2 induces AMOTL1
ubiquitination. Ectopic expression of HECW2 induced AMOTL1
polyubiquitination but the C1540Amutant did not (Fig. 3C and Supple-
mentary Fig. 4). Polyubiquitination leads to different functional conse-
quences depending on the polyubiquitin chains linked through K48,
K63, or other K residues of Ub. Although K48-linked polyubiquitin
chains target substrates in the 26S proteasome for degradation, K63-
linked polyubiquitin chains initiate non-degradation signaling, includ-
ing stabilization and translocalization [33–35]. To further conﬁrm this
result, two different ubiquitin mutants K48R and K63R were used. Con-
sistently, HECW2-mediated AMOTL1 polyubiquitination was supported
byWT and K48R Ub, but not by K63R Ub (Fig. 3D). These results clearly
indicate that HECW2 ubiquitinates AMOTL1 with K63-linked
polyubiquitin chains. Furthermore, we clariﬁed whether subcellular lo-
calization of the stabilized AMOTL1 is altered by HECW2. First, we ex-
amined the localization of AMOTL1 using an antibody against AMOTL1
and also conﬁrmed whether siRNA of AMOTL1 effectively targeted the
AMOTL1 gene in HUVECs. Western blot and immunoﬂuorescence analy-
sis revealed that AMOTL1 was localized in the EC junction area and that
siAMOTL1-transfected HUVECs showed remarkably decreased AMOTL1
expression (Supplementary Fig. 5A and B). Overexpressed HECW2WT
but not the C1540A mutant induced AMOTL1 localization to the tight
junction area (Fig. 3E). These data suggest that, in contrast to NEDD4.2,
HECW2 promoted AMOTL1 protein and tight junction stability.
3.5. Depletion of HECW2 decreased AMOTL1 protein stability in ECs
Aprevious study demonstrated that AMOTL1 regulates EC junctional
stability [8]. To conﬁrm this, we performed immunostaining using anti-
bodies against ZO-2 and VE-CADHERIN, which are the well-known
markers for tight junctions and adherent junctions, respectively.
siAMOTL1-transfected HUVECs showed disrupted VE-CADHERIN and
ZO-2 staining as indicated by white arrows (Supplementary Fig. 6A).
To clarify whether stabilization of AMOTL1 by HECW2 is required for
EC tight junctions, we silencedHECW2using siRNA inHUVECs. Through
RT-PCR andQ-PCR analysis,we found that siHECW2 transfection did not
alter AMOTL1 mRNA expression (Fig. 4A). However, knockdown of
HECW2 markedly decreased AMOTL1 protein levels in HUVECs (Fig.
4B). In general, as K48-linked polyubiquitination of substrates leads to
Fig. 2.HECW2 interacts with AMOTL1. (A) EndogenousHECW2 binds to AMOTL1. HUVEC cell lysateswere immunoprecipitated using the anti-HECW2 antibody, and immunoprecipitated
proteins were analyzed using the anti-AMOTL1 antibody. (B) Exogenous HECW2 interacts with exogenous AMOTL1. Plasmids expressing HA-HECW2 alone or with FLAG-AMOTL1 were
transfected into 293T cells. Whole-cell lysates (WCL) were immunoprecipitated with an anti-HA antibody, and both immunoprecipitates and WCLs were immunoblotted using anti-HA
and anti-FLAG antibodies. (C) Endogenous AMOTL1 binds to HECW2. HUVEC cell lysates were immunoprecipitated using the anti-AMOTL1 antibody, and immunoprecipitated proteins
were analyzed using the anti-HECW2 antibody. (D) Exogenous AMOTL1 interacts with exogenous HECW2. Plasmids expressing FLAG-AMOTL1 alone or with HA-HECW2 were
transfected into 293T cells. Whole-cell lysates (WCL) were immunoprecipitated with an anti-FLAG antibody, and both immunoprecipitates and WCLs were immunoblotted using anti-
HA and anti-FLAG antibodies. (E) Schematic of a series of HECW2-deletion mutants. (F) FLAG-HECW2-deletion mutants and HA-AMOTL1 were transfected into HEK293T cells. Cell
lysates were immunoprecipitated with anti-FLAG antibody. Both the lysate and immunoprecipitates were immunoblotted using the anti-FLAG and anti-HA antibodies.
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calization, signaling, and stabilization, we ﬁrst tested whether HECW2
affects any of these characteristics of AMOTL1 using siRNA-knockdown
of HECW2. We checked the stability of the AMOTL1 protein after CHX
treatment in siCON- or siHECW2-transfected HUVECs. Depletion of
HECW2 decreased the half-life of the AMOTL1 protein, conﬁrming the
importance of HECW2 in regulating AMOTL1 stability (Fig. 4C). Knock-
down of HECW2 decreased AMOTL1 localization to tight junction
areas (Fig. 4D). Therefore, these results suggest that depletion of
HECW2 diminishes cell-to-cell junctions via AMOTL1 destabilization.
3.6. HECW2 depletion induced translocation of YAP into the nucleus
AMOTL1 is a negative regulator of YAP that acts by triggering its
phosphorylation via LATS1/2. Once YAP is dephosphorylated byAMOTL1 depletion, cytoplasmic YAP moves into the nucleus to regu-
late downstream target genes [36,37]. We hypothesized that HECW2
may be involved in the translocation of YAP via AMOTL1 stabilization
in ECs. To test this hypothesis, we examined YAP immunostaining in
AMOTL1- or HECW2-depleted ECs. AMOTL1 or HECW2 depletion in-
creased nuclear YAP compared with that in the control (Fig. 5A and
Supplementary Fig. 6B). We performed fractionation of ECs to deter-
mine YAP localization and analyzed the fractions by Western blot-
ting analysis. Knockdown of or HECW2 showed decreased cytosolic
YAP and increased nuclear YAP, indicating that HECW2 altered YAP
cellular localization by regulating its phosphorylation. We also
found that AMOTL1 levels were decreased in cytosolic fractions,
strongly suggesting that the expression level of AMOTL1 may be
closely related to translocation of YAP (Fig. 5B and C and Supplemen-
tary Fig. 6C).
Fig. 3.HECW2 stabilizes AMOTL1 protein by K63-linked ubiquitination. (A) Exogenous HECW2 upregulates exogenous AMOTL1 protein levels. A combination of plasmids expressing HA-
HECW2, Flag-AMOTL1, and GFP were transfected into 293T cells. WCLwere analyzed by immunoblotting. GFP was used as a control. (B) Exogenous HECW2WT upregulates endogenous
AMOTL1 protein levels but exogenous HECW2 C1540Amutant does not. Extracts of 293T cells transfectedwith plasmids expressing HECW2WT or the C1540Amutant were analyzed by
immunoblotting with anti-HA, anti-AMOTL1, and an anti-beta-ACTIN antibody. (C) The C1540A mutant cannot induce polyubiquitination of AMOTL1. Combinations of plasmids were
transfected, as indicated, into 293T cells with MG132 for 6 h before harvest. Ubiquitinated forms of AMOTL1 were detected using anti-V5 antibody (upper panel). (D) HECW2 utilized
K63-linked polyubiquitination of AMOTL1. Different types of ubiquitin mutant were transfected into 293T cells with a combination of plasmids, as indicated above. The cell lysate was
immunoprecipitated using an antibody against FLAG and was immunoblotted with an antibody against HA to detect ubiquitination. (E) HECW2 overexpression promotes AMOTL1 in
endothelial cell junctions. HUVECs were infected with Lentivirus MOCK, HECW2 WT, and HECW2 C1540A. Infected HUVECs were stained with the anti-AMOTL1 and anti-FLAG
antibodies. The arrows indicate tight junction areas.
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ANG-2
As we showed in Fig. 1F, HECW2-depleted cells showed increased
angiogenic sprouting. Interestingly, AMOTL1-depleted cells alsoexhibited increased angiogenic sprouting (Supplementary Fig. 7A and
B). Our previous study revealed that YAP activation induced by junction
destabilization increased ANG-2 expression, thereby promoting angio-
genic sprouting. To investigate whether HECW2 is also involved in
YAP-mediated ANG-2 pathway, we examined ANG-2 levels in
Fig. 4. Loss of HECW2 decreases AMOTL1 protein stability in HUVECs. (A) siCON- or siHECW2-transfected HUVECs were analyzed by RT-PCR (left) and Q-PCR (right). (B) siCON- or
siHECW2-transfected HUVECs were analyzed by Western blotting analysis. (C) HUVECs were transfected with the control and HECW2 siRNAs followed by treatment with or without
CHX and were then lysed and immunoblotted with anti-HECW2, anti-AMOTL1, and anti-beta-ACTIN antibodies. (D) Loss of HECW2 decreases AMOTL1 in endothelial cell junctions.
HUVECs were transfected with control or HECW2 siRNA. Transfected HUVECs were stained with anti-AMOTL1 antibody. The arrows indicate tight junction areas. The number of
AMOTL1-positive cells was counted in siCON- or siHECW2-transfected HUVECs.
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of both ANG-2 protein and RNA (Fig. 6A and B). Moreover, knockdown
of AMOTL1 showed increased ANG-2 expression (Supplementary Fig.
7C). The increase in sprouting following HECW2 depletion was blocked
by ANG-2 knockdown (Fig. 6C and D). Therefore, these data implicate
HECW2 as an important regulator of AMOTL1-YAP pathway-mediated
regulation of angiogenesis.
4. Discussion
Herewe identify HECW2 as a novel E3 ligase in ECs and demonstrate
that it plays regulatory roles in EC junction stability and angiogenic ac-
tivation. A previous study has shown that HECW2enhances p73 proteinstability via polyubiquitination in non-ECs and increases its transcrip-
tional activity [13]. p73 is important in EC differentiation and
vasculogenesis by regulating VEGF and TGFβ signaling. p73-deﬁciency
results in reduced VEGF and TGFβ signaling and impaired angiogenic
sprouting in mESCs [38,39]. Based on a study on p73 and HECW2,
HECW2 deﬁciency is supposed to show impaired angiogenesis. Howev-
er, HECW2 did not change p73 protein stability in ECs. On the other
hand, HECW2 deﬁciency showed promoted sprouting angiogenesis
and this data suggested that p73 and HECW2 deﬁciency showed oppo-
site phenomena.
Cell-to-cell junctions in ECs maintain vessel integrity, and junction
stability is tightly regulated by post-translational modiﬁcations, such
as ubiquitination [40,41]. To date, over 30 HECT-type ubiquitin ligases
Fig. 5.HECW2depletion induced translocation of YAP into the nucleus. (A) Immunoﬂuorescence analysis of YAP inHECW2 siRNA-treatedHUVECswas conducted using antibodies against
YAP. The arrows indicate nuclear YAP. (B) Intracellular localization of YAP was quantiﬁed. (C) The cytosolic or nuclear fractions of cell lysates were immunoblotted with anti-HECW2,
AMOTL1, YAP, and phospho-YAP (S127) antibodies. Anti-LAMIN A/C and GAPDH were used as loading controls.
1649K.-S. Choi et al. / Cellular Signalling 28 (2016) 1642–1651are known and are reported to participate in various cellular processes
[19,42]. Among them, only a few have been studied in the context of
EC junction stability. ITCH (also known as AIP) is an E3 ligase of
occludin. The ubiquitin-induced trafﬁcking of occludin promotes
VEGF-induced vascular permeability [43]. Another E3 ligase, NEDD4.2,
targets AMOTL1 for ubiquitin-dependent degradation, leading to its
mislocalization from the tight junctions [12]. On the contrary, we iden-
tify HECW2 as another key E3 ligase for AMOTL1. However, unlike
NEDD4.2, HECW2 increased protein stability of AMOTL1 via K63-linked
ubiquitination and increased its localization to junction areas in
HUVECs. HECW2-depleted cells showed mislocalization of AMOTL1
away from the tight junctions. Although the molecular mechanisms of
regulation of AMOTL1 by NEDD4.2 and HECW2 in ECs are still under in-
vestigation, our ﬁndings suggest that there is an inverse regulation of
AMOTL1 protein stability by E3 ligases.
Recent studies have shown that AMOT and AMOTL1 exhibited simi-
lar functions by interacting with and regulating tight junction proteins,
including ZO-1 and YAP [44,45]. AMOT-deﬁcient mice showed dilated
vessels in the brain, resulting in severe lethality between E11 and
E11.5; only 5% survived without any vascular defects [46]. Thus, other
family members may compensate for loss of AMOT. Because of their
conserved domains and known functions, AMOTL1 was the most likely
candidate [8]. We observed that HECW2 interacted with all AMOT fam-
ily members, but AMOT expression was not detected in HUVECs. Thus,
we concluded that junction destabilization by HECW2 depletion might
be mediated by AMOTL1.AMOTL1was suggested to be an upstream negative regulator of YAP
through direct binding, leading to tight junction localization and cyto-
solic retention of YAP. Knockdown of the AMOT family members in
MDCK cells leads to loss of tight junction localization and nuclear accu-
mulation of YAP and induction of YAP target gene expression [45]. YAP
is a transcriptional co-activator of the Hippo pathway, which is tightly
regulated by cell-to-cell contacts [47–49]. We have previously reported
that YAP directly regulates the transcription level of ANG-2 in sprouting
angiogenesis [24]. However, the underlying mechanism and the genes
involved in regulation of YAP in ECs remain unclear. We found that
YAP was translocated into the nucleus by depletion of HECW2 and
that this nuclear YAP augmented ANG-2 expression, thereby promoting
EC sprouting. Although the mechanism by which HECW2 is regulated
in ECs is still being investigated, our current study provides new
insights into the regulatory mechanisms of YAP-mediated sprouting
angiogenesis.
In conclusion, here we introduce an important mechanism
connecting EC junction stability and sprouting angiogenesis. The
known role of the AMOTL1-YAP pathway is highly consistent with our
ﬁnding that depletion of HECW2 increased ANG-2 expression. We
show for the ﬁrst time the mechanism by which HECW2 regulates the
AMOTL1-YAP pathway in ECs. Thus, our ﬁndings provide important in-
sights into the role of HECW2, as an E3-ligase, in regulating EC junction
stability.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.cellsig.2016.07.015.
Fig. 6. Endothelial sprouting induced by HECW2 depletion is mediated by ANG-2. (A) The mRNA expression of ANG-2 in shCON- or shHECW2-infected HUVECs was analyzed by RT-PCR
(left) and Q-PCR (right). (B) The protein expression of ANG-2 in shCON- or shHECW2-infected HUVECs was analyzed by Western blotting analysis. Data are shown as mean ± SEM of
values from a representative experiment. (C) After HUVECs were transfected with siCON or siHECW2 with or without siANG-2, respectively, the bead-sprouting assay was performed
and was replenished with 2% EGM medium every other day. (D) The number of sprouts or cumulative sprout length derived per bead was counted after 4 days of incubation. Data are
shown as mean ± SEM of values from a representative experiment. ***p b 0.0001 vs siCON transfected cells; ###p b 0.0001 vs siHECW2 + siANG-2-transfected cells (two-tailed
Student's t-test).
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